文献速递糖尿病肥胖与代谢综合征

DiRECT 试验:减重期间降压药需求与血压控制

Antihypertensive medication needs and blood pressure control with weight loss in the Diabetes Remission Clinical Trial (DiRECT).
PubMed 文献 · Diabetologia · 2021-05-31

DiRECT 干预组的事后分析评估了在开始配方低能量饮食替代时按计划停用所有降压药和利尿剂的安全性与有效性。143 名干预组参与者中 78 人基线接受高血压治疗,其中 65 人按方案停用所有降压药,4 人停用部分药物。停药的 69 人第一周内血压无立即变化,但平均血压从第 9 周起显著下降;19/69(27.5%)在总饮食替代期间因血压升高需重新引入降压药,多数发生在最初 3-7 周内。

要点

  • 开始总饮食替代时停用降压药安全,但需定期监测血压。
  • 服用两种及以上降压药者超三分之二需重新引入药物。
  • 总饮食替代期间可能出现轻度头晕,提示体位性低血压。

核心结论

  • 用 3470 kJ/天(830 kcal)饮食诱导减重替代降压药可显著降低血压,但可能增加轻度头晕。
  • 停用降压药是安全的,但应定期监测血压,尤其对服用两种及以上降压药者,因超三分之二将需重新引入部分药物。
  • 长期支持维持减重至关重要。

研究设计与样本

  • DiRECT 干预组的事后分析,共 143 人,其中 69 人在总饮食替代开始时停用降压药。
  • Counterweight-Plus 总饮食替代提供约 3470 kJ/天(830 kcal),持续 12-20 周,定期监测血压并按指南重新引入降压药。

主要发现

  • 143 名干预组参与者中 78 人(55%)基线接受高血压治疗。
  • 78 人中 65 人(83%)按方案停用所有降压药和利尿剂,4 人(5%)停用部分药物。
  • 停药的 69 人第一周内血压无立即变化,但平均血压从第 9 周起显著下降。
  • 19/69(27.5%)在总饮食替代期间因血压升高重新引入降压药,多数在最初 3-7 周内。
  • 重新引入者中 5/19 先前用一种药,14/19 先前用两种或以上药物;69 人中 19 人(28%)在 24 个月时仍未用药。

关键数值与推荐

  • 总饮食替代提供约 3470 kJ/天(830 kcal),持续 12-20 周。
  • 19/69(27.5%)需重新引入降压药,多数在最初 3-7 周内。
  • 24 个月时 19/69(28%)仍停药;53 人达到持续糖尿病缓解(平均减重 11.4 kg),其中 31 人曾接受高血压治疗,27 人基线停药,15/27 需重新引入降压药。
  • 51 人报告轻中度头晕,其中 15 人基线即有头晕记录,9 人服用降压药或利尿剂。

临床怎么用

  • 在开始总饮食替代时可安全停用降压药,但需定期监测血压。
  • 对服用两种及以上降压药者应特别警惕,超三分之二需重新引入药物。
  • 总饮食替代期间出现轻度头晕可能提示体位性低血压,需关注。
  • 需长期支持维持减重。

局限性

  • 为事后分析。
  • 样本量有限(干预组 143 人,停药亚组 69 人)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Our aim was to evaluate the safety and efficacy of a planned therapeutic withdrawal of all antihypertensive and diuretic medications, on commencing a formula low-energy diet replacement, targeting remission of type 2 diabetes. METHODS: Post hoc analysis of changes in BP, antihypertensive medication prescriptions and symptoms during the initial total diet replacement phase was performed in the intervention arm of the Diabetes Remission Clinical Trial (n = 143) and in the subset (n = 69) who discontinued antihypertensive medications at the start of total diet replacement. The Counterweight-Plus total diet replacement provided about 3470 kJ/day (830 kcal) with automatic reductions in all nutrients, including sodium, to achieve marked negative energy balance and rapid weight loss over 12-20 weeks, with regular BP monitoring and an antihypertensive reintroduction protocol based on current clinical guidelines. RESULTS: Of 143 intervention group participants who commenced total diet replacement, 78 (55%) were on treatment for hypertension at baseline. The overall mean BP fell significantly from the start of total diet replacement (week 1) and was significantly lower at week 20, after total diet replacement finished, and also at 12 and 24 months. Of the 78 participants previously on treatment for hypertension, 65 (83%) stopped all antihypertensive and diuretic medications as per protocol, and four (5%) stopped some drugs. These 69 participants experienced no immediate (within the first week) change in BP, but their mean BP fell significantly from 9 weeks. No excessive rises in BP were recorded in individuals, but antihypertensive medications were reintroduced during total diet replacement to manage raised BP for 19/69 (27.5%) participants, mostly within the first 3-7 weeks, despite some weight loss. Reintroduction of antihypertensive medications was necessary for 5/19 participants previously on one drug, and for 14/19 previously on two or more drugs. Of the 69 who stopped antihypertensives, 19 (28%) remained off medications at 24 months. Among the 53 participants who achieved sustained remissions of diabetes at 24 months (with a mean weight loss of 11.4 kg), 31 had been previously treated for hypertension. Twenty-seven stopped medication at baseline, and 15/27 required reintroduction of antihypertensive medications. Mild to moderate dizziness, suggesting some postural hypotension, was reported during total diet replacement by 51 participants, 15 of whom had recorded dizziness at baseline prior to starting total diet replacement, with nine of these on antihypertensive or diuretic medications. CONCLUSIONS/INTERPRETATION: Replacing antihypertensive medications with a 3470 kJ/day (830 kcal) diet to induce weight loss reduces BP substantially and may increase mild dizziness. It is safe to stop antihypertensives, but BP should be monitored regularly, particularly for those taking two or more antihypertensives, as over two-thirds will require reintroduction of some medications. Long-term support to maintain weight loss is vital. TRIAL REGISTRATION: ISRCTN registry, number 03267836.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Leslie WS, Ali E, Harris L, et al. Antihypertensive medication needs and blood pressure control with weight loss in the Diabetes Remission Clinical Trial (DiRECT). Diabetologia. 2021. PMID: 34056684. doi:10.1007/s00125-021-05471-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。